These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26305875)

  • 1. iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors.
    Crabb JW; Hu B; Crabb JS; Triozzi P; Saunthararajah Y; Tubbs R; Singh AD
    PLoS One; 2015; 10(8):e0135543. PubMed ID: 26305875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics of Primary Uveal Melanoma: Insights into Metastasis and Protein Biomarkers.
    Jang GF; Crabb JS; Hu B; Willard B; Kalirai H; Singh AD; Coupland SE; Crabb JW
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of fourteen proteins between uveal melanoma from patients who subsequently developed distant metastases versus those who did Not.
    Linge A; Kennedy S; O'Flynn D; Beatty S; Moriarty P; Henry M; Clynes M; Larkin A; Meleady P
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4634-43. PubMed ID: 22570344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss.
    Coupland SE; Vorum H; Mandal N; Kalirai H; Honoré B; Urbak SF; Lake SL; Dopierala J; Damato B
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):12-20. PubMed ID: 19643972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
    All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-depth proteomic profiling of the uveal melanoma secretome.
    Angi M; Kalirai H; Prendergast S; Simpson D; Hammond DE; Madigan MC; Beynon RJ; Coupland SE
    Oncotarget; 2016 Aug; 7(31):49623-49635. PubMed ID: 27391064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
    Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
    Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock protein expression in the eye and in uveal melanoma.
    Missotten GS; Journée-de Korver JG; de Wolff-Rouendaal D; Keunen JE; Schlingemann RO; Jager MJ
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3059-65. PubMed ID: 12824252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crizotinib, a c-Met inhibitor, prevents metastasis in a metastatic uveal melanoma model.
    Surriga O; Rajasekhar VK; Ambrosini G; Dogan Y; Huang R; Schwartz GK
    Mol Cancer Ther; 2013 Dec; 12(12):2817-26. PubMed ID: 24140933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics in uveal melanoma.
    Ramasamy P; Murphy CC; Clynes M; Horgan N; Moriarty P; Tiernan D; Beatty S; Kennedy S; Meleady P
    Exp Eye Res; 2014 Jan; 118():1-12. PubMed ID: 24056206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoexpression of SPANX-C in metastatic uveal melanoma.
    Salvatorelli L; Puzzo L; Russo A; Reibaldi M; Longo A; Ragusa M; Aldo C; Rappazzo G; Caltabiano R; Salemi M
    Pathol Res Pract; 2019 Jul; 215(7):152431. PubMed ID: 31072624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic uveal melanoma: biology and emerging treatments.
    Woodman SE
    Cancer J; 2012; 18(2):148-52. PubMed ID: 22453016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAM 10 expression in primary uveal melanoma as prognostic factor for risk of metastasis.
    Caltabiano R; Puzzo L; Barresi V; Ieni A; Loreto C; Musumeci G; Castrogiovanni P; Ragusa M; Foti P; Russo A; Longo A; Reibaldi M
    Pathol Res Pract; 2016 Nov; 212(11):980-987. PubMed ID: 27546281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the typical multidrug resistance profile in human uveal melanoma cell lines and in mouse liver metastasis derivatives.
    Labialle S; Dayan G; Gambrelle J; Gayet L; Barakat S; Devouassoux-Shisheboran M; Bernaud J; Rigal D; Grange JD; Baggetto LG
    Melanoma Res; 2005 Aug; 15(4):257-66. PubMed ID: 16034303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
    Mallikarjuna K; Vaijayanthi P; Krishnakumar S
    Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis.
    Chang SH; Worley LA; Onken MD; Harbour JW
    Melanoma Res; 2008 Jun; 18(3):191-200. PubMed ID: 18477893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of differentially expressed genes and functional annotations associated with metastases of the uveal melanoma.
    Xu Y; Han W; Xu WH; Wang Y; Yang XL; Nie HL; Yao J; Shen GL; Zhang XF
    J Cell Biochem; 2019 Nov; 120(11):19202-19214. PubMed ID: 31270856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMT-associated factors promote invasive properties of uveal melanoma cells.
    Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
    Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased chondroitin sulphate proteoglycan expression (B5 immunoreactivity) in metastases of uveal melanoma.
    Kiewe P; Bechrakis NE; Schmittel A; Ruf P; Lindhofer H; Thiel E; Nagorsen D
    Ann Oncol; 2006 Dec; 17(12):1830-4. PubMed ID: 16971663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of metastasis of uveal melanoma: comparison of morphometric determination of nucleolar size and spectrophotometric determination of DNA.
    McLean IW; Gamel JW
    Invest Ophthalmol Vis Sci; 1988 Apr; 29(4):507-11. PubMed ID: 3356509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.